Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1896
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer ; volume:16 ; number:1 ; day:4 ; month:1 ; year:2018 ; pages:145 ; date:2.2018
Applied health economics and health policy ; 16, Heft 1 (4.1.2018), 145, 2.2018
- Schlagwort
-
Gesundheitsförderung
Gesundheit
- Urheber
-
Peters, Michel L.
- Beteiligte Personen und Organisationen
-
Meijer, Claudine de
Wyndaele, Dirk
Noordzij, Walter
Leliveld-Kors, Annemarie M.
Bosch, Joan van den
Berg, Pieter H. van den
Baka, Agni
Gaultney, Jennifer G.
SpringerLink (Online service)
- DOI
-
10.1007/s40258-017-0364-4
- URN
-
urn:nbn:de:1111-2018032910108
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Peters, Michel L.
- Meijer, Claudine de
- Wyndaele, Dirk
- Noordzij, Walter
- Leliveld-Kors, Annemarie M.
- Bosch, Joan van den
- Berg, Pieter H. van den
- Baka, Agni
- Gaultney, Jennifer G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Physician preferences for non-metastatic castration-resistant prostate cancer treatment
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer